Evidence-Based Updates: Respiratory Immunization Clinical Guidelines
* You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
In this presentation, speakers Dr. Michael Dudas, Dr. David Schmidt, and Dr. Renuga Vivekanandan discuss the changing policies around immunization recommendations and the subsequent updates in respiratory immunization guidelines for children and adults. They differentiate between the diverging recommendations from the CDC, FDA, and professional societies. Panelists Dr. Ankita Sagar and Dr. Thomas McGinn review clinical evidence that supports the practice guidelines and promote improved quality of patient care.
This Common Spirit Health Clinical Grand Rounds session took place on Friday, October 17, 2025 at 9:00 a.m.
Activity Information
How to Claim Credit
You may claim credit after watching this activity.
You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
Needs Statement
To address the professional practice gaps in delivering consistent, high-quality, evidence-based care across the Physician Enterprise and CommonSpirit Health, clinicians require targeted education that promotes the consistent application of evidence-based medicine. This includes training that supports the adoption of the CommonSpirit Standard of Care, particularly in clinical areas with high visibility, variation in practice, patient volume, and value. Providers need practical tools and frameworks to interpret and integrate evolving clinical guidelines into their daily workflows, ensuring that new evidence translates into improved patient outcomes. Additionally, education must foster strong interprofessional collaboration by emphasizing shared goals, clear roles, mutual trust, and effective communication among care team members. Recognizing the impact of provider burnout on care quality, educational initiatives should also address workforce well-being by promoting team-based documentation, role optimization, and workflow redesign to reduce administrative burden and enhance job satisfaction.
Educational Objectives
At the conclusion of the activity, the participants should be able to:
- Discuss the changes in the policy and regulatory landscape over the last several months.
- Describe the epidemiology associated with COVID-19, influenza, pneumococcal, and respiratory syncytial virus infections.
- Differentiate current recommendation for pediatric and adult immunizations from the U.S. Centers for Disease Control and Prevention and its Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration, and professional societies.
- Recognize the importance of reviewing and discussing new clinical evidence in the context of improving care delivery and patient outcomes.
Target Audience
Professional Categories
- Physicians
- Fellows
- Residents
- Other Health Professionals
Specialties
- Infectious Disease
- Internal Medicine
Interest Groups
- Primary Care
- Quality Improvement and Patient Safety
Activity Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.
Educational Methods
- Lectures
- Panel Discussion
Accreditation/Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and CommonSpirit Health. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
-
Ankita Sagar, M.D., M.P.H.
Associate Professor
Creighton University School of Medicine, CommonSpirit Health
Panelist
-
-
Ankita Sagar, M.D., M.P.H.
Associate Professor
Creighton University School of Medicine, CommonSpirit Health
Term of Approval
October 1, 2025 through October 31, 2027. Original release date: October 1, 2025.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenters
-
Michael Dudas, M.D.
Chief of Pediatrics
Virginia Mason Franciscan Health
Disclosure:
Nothing to disclose.
-
David Schmidt, Pharm.D.
System Director, Clinical Pharmacy and Medication Safety
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Renuga Vivekanandan, M.D.
Division Vice President and Chief Medical Officer; Professor and Division Chief of Infectious Disease
Physician Enterprise, CHI Health; Creighton University School of Medicine
Disclosure:
Nothing to disclose.
Activity Director
-
Ankita Sagar, M.D., M.P.H.
Associate Professor
Creighton University School of Medicine, CommonSpirit Health
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Rachel Lytle Bates, R.N., M.S.N., C.P.H.Q.
System Director for Clinical Standards and Variation Reduction
CommonSpirit Health Physician Enterprise
Disclosure:
Nothing to disclose.
-
-
Sara Glaser, B.S.N., M.B.A.
System Director, Hospital Medicine Operations
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Gary Greensweig, D.O.
Chief Physician Executive
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
John Kniesche, M.P.H.
System Director, Clinical Support Services, Physician Enterprise
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Ankita Sagar, M.D., M.P.H.
Associate Professor
Creighton University School of Medicine, CommonSpirit Health
Disclosure:
Nothing to disclose.
Panelist
-
Thomas McGinn, M.D., M.P.H.
Executive Vice President Physician Enterprise
CommonSpirit Health
Disclosure:
Nothing to disclose.
-
Ankita Sagar, M.D., M.P.H.
Associate Professor
Creighton University School of Medicine, CommonSpirit Health
Disclosure:
Nothing to disclose.
Health Topics
Presenters:
David Schmidt, Pharm.D.
System Director, Clinical Pharmacy and Medication Safety CommonSpirit Health